share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bhatia Sangeeta N.

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bhatia Sangeeta N.

福泰製藥 | 4：持股變動聲明-董事 Bhatia Sangeeta N.
美股sec公告 ·  05/04 04:10
牛牛AI助理已提取核心訊息
Sangeeta N. Bhatia, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a sale of company stock on May 2, 2024. The transaction involved the disposal of 467 shares of common stock at a price of $402.95 per share, resulting in a total market value of $188,177.65. This sale followed an acquisition of 1,001 shares on May 1, 2024, which were granted at no cost. After these transactions, Bhatia's direct holdings in Vertex Pharmaceuticals totaled 4,435 shares. The sale took place in the open market and is part of the normal course of stock trading for company insiders.
Sangeeta N. Bhatia, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a sale of company stock on May 2, 2024. The transaction involved the disposal of 467 shares of common stock at a price of $402.95 per share, resulting in a total market value of $188,177.65. This sale followed an acquisition of 1,001 shares on May 1, 2024, which were granted at no cost. After these transactions, Bhatia's direct holdings in Vertex Pharmaceuticals totaled 4,435 shares. The sale took place in the open market and is part of the normal course of stock trading for company insiders.
與Vertex Pharmicals Inc.（VRTX）相關的桑吉塔·巴蒂亞於2024年5月2日完成了公司股票的出售。該交易涉及以每股402.95美元的價格出售467股普通股，總市值爲188,177.65美元。此次出售是在2024年5月1日收購了1,001股股票之後進行的，這些股票是免費授予的。在這些交易之後，巴蒂亞在Vertex Pharmicals的直接持股總額爲4,435股。此次出售是在公開市場上進行的，是公司內部人士正常股票交易過程的一部分。
與Vertex Pharmicals Inc.（VRTX）相關的桑吉塔·巴蒂亞於2024年5月2日完成了公司股票的出售。該交易涉及以每股402.95美元的價格出售467股普通股，總市值爲188,177.65美元。此次出售是在2024年5月1日收購了1,001股股票之後進行的，這些股票是免費授予的。在這些交易之後，巴蒂亞在Vertex Pharmicals的直接持股總額爲4,435股。此次出售是在公開市場上進行的，是公司內部人士正常股票交易過程的一部分。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。